Philipp Frech - Evolva Holding Gen Board
| EVE Stock | CHF 0.81 0.06 6.90% |
Insider
Philipp Frech is Gen Board of Evolva Holding SA
| Phone | 41 61 485 2000 |
| Web | https://www.evolva.com |
Evolva Holding Management Efficiency
The company has return on total asset (ROA) of (0.1134) % which means that it has lost $0.1134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3693) %, meaning that it generated substantial loss on money invested by shareholders. Evolva Holding's management efficiency ratios could be used to measure how well Evolva Holding manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Adesh Kaul | Basilea Pharmaceutica AG | 49 | |
| U Gantner | VAT Group AG | N/A | |
| Rahma Samow | Straumann Holding AG | 44 | |
| Holger Haderer | Straumann Holding AG | 54 | |
| Michael Allison | VAT Group AG | 61 | |
| J Haggerty | VAT Group AG | N/A | |
| Peter Hackel | Straumann Holding AG | 54 | |
| Guillaume Daniellot | Straumann Holding AG | 53 | |
| G Lutz | VAT Group AG | N/A | |
| Caroline MD | Lonza Group AG | 51 | |
| Dirk Oehlers | Lonza Group AG | N/A | |
| Damian Heller | Basilea Pharmaceutica AG | 57 | |
| Gerrit Hauck | Basilea Pharmaceutica AG | 59 | |
| Lutz Wevelsiep | Basilea Pharmaceutica AG | N/A | |
| Jennifer Clancy | Lonza Group AG | N/A | |
| Andreas Bohrer | Lonza Group AG | N/A | |
| Victoria Morgan | Lonza Group AG | N/A | |
| David Veitch | Basilea Pharmaceutica AG | 58 | |
| Peer Schroder | Basilea Pharmaceutica AG | N/A | |
| Aurelio Sahagun | Straumann Holding AG | 50 | |
| V Valentin | VAT Group AG | N/A | |
Management Performance
| Return On Equity | -0.37 | |||
| Return On Asset | -0.11 |
Evolva Holding SA Leadership Team
Elected by the shareholders, the Evolva Holding's board of directors comprises two types of representatives: Evolva Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolva. The board's role is to monitor Evolva Holding's management team and ensure that shareholders' interests are well served. Evolva Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolva Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Oliver MBA, Advisor | ||
| Anne Vos, Chief Officer | ||
| Christian Wichert, Chief Officer | ||
| Fabienne Gschwind, Head HR | ||
| Thomas CFA, Head Relations | ||
| Kaspar Mueller, Head Protection | ||
| Gerhard Lobmaier, Chief Officer | ||
| Astrid Schafer, Head RD | ||
| Philipp Frech, Gen Board | ||
| Carsten Daweritz, Chief Officer |
Evolva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Evolva Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.37 | |||
| Return On Asset | -0.11 | |||
| Operating Margin | (2.31) % | |||
| Current Valuation | 91.22 M | |||
| Shares Outstanding | 1.11 B | |||
| Shares Owned By Insiders | 0.66 % | |||
| Shares Owned By Institutions | 25.03 % | |||
| Price To Earning | (4.33) X | |||
| Price To Book | 0.75 X | |||
| Price To Sales | 7.35 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evolva Stock Analysis
When running Evolva Holding's price analysis, check to measure Evolva Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolva Holding is operating at the current time. Most of Evolva Holding's value examination focuses on studying past and present price action to predict the probability of Evolva Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolva Holding's price. Additionally, you may evaluate how the addition of Evolva Holding to your portfolios can decrease your overall portfolio volatility.